Cite
MLA Citation
Silvy Mardiguian et al.. “Cost-benefits of incorporating levosimendan into cardiac surgery practice: German base case.” Journal of medical economics, vol. 19, 2016, pp. 506–514. http://access.bl.uk/ark:/81055/vdc_100033993032.0x00004f